From: OncLive <edigest@onclive.com>
Sent: <Day, Month xx, 2020>
To: <<Email Address>>
Subject: Save the Date for a Live Broadcast on a New Combination Treatment for Patients with aRCC
No Images? Click here
|
|
|
LIVE BROADCAST
[Month, Date, Year 00:00 (EST)]
|
|
|
Discover a New Combination Treatment for Patients With Advanced Renal Cell Carcinoma
OncLive® invites you to join the experts for a live broadcast to learn about a new combination regimen for the treatment of advanced renal cell carcinoma (aRCC). In this broadcast, thought leaders will review the epidemiology of RCC, discuss mechanisms of action of a multitargeted approach to treatment, review the efficacy and safety data for a new combination regimen, and share clinical insights through a live Q&A.
|
|
This program is intended for US Healthcare Professionals including: Oncologists, NPs, PAs, RNs, Pharmacists.
Program is not intended for non-healthcare professionals, including guests or spouses.
|
|
|
[Fullname, Credentials]
[Faculty Title]
[Faculty Institution]
[Faculty City, State]
|
|
|
[Fullname, Credentials]
[Faculty Title]
[Faculty Institution]
[Faculty City, State]
|
|
|
[Fullname, Credentials]
[Faculty Title]
[Faculty Institution]
[Faculty City, State]
|
|
|
|
CA-1715 09/20
This program is not certified for Continuing Medical Education credit.
This program is intended for US Healthcare Professionals including: Oncologists, NPs, PAs, RNs, Pharmacists. Program is not intended for non-healthcare professionals, including guests or spouses.
|
|
|
|
OncLive® – an MJH Life Sciences™ brand
Copyright 2020 © Intellisphere, LLC
2 Clarke Dr | Suite 100 | Cranbury, NJ | 08512
Preferences | Unsubscribe
|
|
|